Determination of reference values for total PSA, F/T and PSAD according to prostatic volume in Japanese prostate cancer patients with slightly elevated serum PSA levels

被引:12
|
作者
Kuriyama, M [1 ]
Uno, H [1 ]
Watanabe, H [1 ]
Yamanaka, H [1 ]
Saito, Y [1 ]
Shida, K [1 ]
机构
[1] Gifu Univ, Sch Med, Dept Urol, Gifu 5008750, Japan
关键词
prostate cancer; PSA gray zone; F/T; PSAD; prostatic volume;
D O I
10.1093/jjco/29.12.617
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: For screening prostate cancer (CAP) using prostate-specific antigen (PSA), the indications of biopsies for patients showing slightly elevated PSA values are still controversial. Furthermore, the dependence of total PSA, free-to-total PSA ratio (F/T) and PSA density (PSAD) on prostatic volume in gray zone cases is unclear. Methods: By analyzing 1913 patients with a serum total PSA ranging from 2.0 to 20 ng/ml, we evaluated the correlation between total PSA and age or prostatic volume and positive predictive value (PPV) in each range for total PSA, age and prostatic volume. Then suitable reference values for total PSA, F/T and PSAD were decided according to prostatic volume. Results: There was no close correlation between PSA and age or volume. The PPV was high in the group with a prostatic volume of 10-30 mi. Prostatic volume was categorized into three groups, <20, 20-40 and greater than or equal to 40 ml, and reference values for obtaining a sensitivity of 90% were proposed. The reference values of total PSA and PSAD were lowered and that of F/T was raised with increase in prostatic volume. The specificity was very low for the greater than or equal to 40 mi group. The highest specificity of 36% in PSAD was obtained for the <20 ml group. Conclusion: The reference values for total PSA, F/T and PSAD must be changed according to prostatic volume in order to maintain a sufficient diagnostic sensitivity of CAP. Of these parameters, PSAD showed a high specificity in the group with a prostatic volume of <40 ml.
引用
收藏
页码:617 / 622
页数:6
相关论文
共 27 条
  • [11] Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels
    Tanaka, N.
    Fujimoto, K.
    Chihara, Y.
    Torimoto, M.
    Hirao, Y.
    Konishi, N.
    Saito, I.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (03) : 274 - 278
  • [12] The ratio of human glandular kallikrein (hK2) to free PSA improves the discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately elevated total PSA levels
    Magklara, A
    Scorilas, A
    Catalona, WJ
    Diamandis, EP
    CLINICAL CANCER RESEARCH, 1999, 5 : 3826S - 3827S
  • [13] Prostate-specific antigen (PSA) complexed to α1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL
    Kobayashi, T
    Kamoto, T
    Nishizawa, K
    Mitsumori, K
    Ogura, K
    Ide, Y
    BJU INTERNATIONAL, 2005, 95 (06) : 761 - 765
  • [14] Prospective multicenter European study of complex PSA, cPSA, cPSAD, cPSA-TZ, c/total PSA ratio, c/free PSA ratio, f/t PSA, PSAD and PSA-TZ for early prostate cancer detection in men with PSA levels between 4-10 ng/mL
    Djavan, B
    Ravery, V
    Zlotta, A
    Dobronski, P
    Gibod, LB
    Kaisary, A
    Schulman, C
    Remzi, M
    Reissigl, A
    Tinzl, M
    Marberger, M
    JOURNAL OF UROLOGY, 2002, 167 (04): : 325 - 325
  • [15] CORRELATION OF SERUM LEVELS OF PROSTATE SPECIFIC ANTIGEN (PSA) WITH TUMOR VOLUME IN 41 PATIENTS WITH PROSTATIC-CARCINOMA (CA)
    TRONCOSO, P
    LLORETA, J
    AYALA, AG
    FERNANDEZ, PL
    RAMIREZ, E
    MACKAY, B
    BABAIAN, RJ
    LABORATORY INVESTIGATION, 1991, 64 (01) : A52 - A52
  • [16] Significant Dignostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution
    Nan, Li-Bin
    Yin, Xiao-Tao
    Gao, Jiang-Ping
    MEDICAL SCIENCE MONITOR, 2019, 25 : 8345 - 8351
  • [17] Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA -: Reply
    Jung, K
    Brux, B
    Lein, M
    Sinha, P
    Schnorr, D
    Loening, SA
    UROLOGY, 1999, 53 (06) : 1168 - 1168
  • [18] Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA -: Comment
    Stenman, UH
    UROLOGY, 1999, 53 (06) : 1167 - 1168
  • [19] Peripheral Zone Prostate Cancer in Patients with Elevated PSA Levels and Low Free-to-Total PSA Ratio: Detection with MR Imaging and MR Spectroscopy
    Vilanova, Joan C.
    Comet, Josep
    Barcelo-Vidal, Carles
    Barcelo, Joaquim
    Lopez-Bonet, Eugeni
    Maroto, Albert
    Arzoz, Montse
    Moreno, Angel
    Areal, Joan
    RADIOLOGY, 2009, 253 (01) : 135 - 143
  • [20] Low Percentage of Free Prostate-specific Antigen (PSA) Is a Strong Predictor of Later Detection of Prostate Cancer Among Japanese Men With Serum Levels of Total PSA of 4.0 ng/mL or Less
    Sasaki, Mitsuharu
    Ishidoya, Shigeto
    Ito, Akihiro
    Saito, Hideo
    Yamada, Shigeyuki
    Mitsuzuka, Koji
    Kaiho, Yasuhiro
    Shibuya, Daisuke
    Yamaguchi, Takuhiro
    Arai, Yoichi
    UROLOGY, 2014, 84 (05) : 1163 - 1167